Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-26

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating the safety and efficacy of ST-1891 hormone replacement therapy compared with Levothyroxine in adults with hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)
  • ST-1891 (ST-1891)

Snippet

Sponsor: Sention Therapeutics, LLC | Conditions: Hypothyroidism | Phase 2 | Status: COMPLETED